Total Payments
$154,794
2024 Payments
$14,827
Companies
39
Transactions
1,156
Medicare Patients
3,008
Medicare Billing
$514,717
Payment Breakdown by Category
Other$117,971 (76.2%)
Food & Beverage$21,803 (14.1%)
Travel$6,545 (4.2%)
Consulting$5,563 (3.6%)
Gifts$2,400 (1.6%)
Education$512.01 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117,971 | 60 | 76.2% |
| Food and Beverage | $21,803 | 1,050 | 14.1% |
| Travel and Lodging | $6,545 | 29 | 4.2% |
| Consulting Fee | $5,563 | 3 | 3.6% |
| Gift | $2,400 | 2 | 1.6% |
| Education | $512.01 | 12 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $70,009 | 192 | $0 (2024) |
| ABBVIE INC. | $27,707 | 138 | $0 (2024) |
| Alkermes, Inc. | $23,593 | 102 | $0 (2024) |
| Allergan, Inc. | $14,654 | 86 | $0 (2021) |
| ITI, Inc. | $3,175 | 34 | $0 (2023) |
| Axsome Therapeutics, Inc. | $2,771 | 16 | $0 (2024) |
| Resmed Corp | $2,400 | 2 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $1,789 | 123 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $1,446 | 57 | $0 (2024) |
| Lundbeck LLC | $1,101 | 75 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,827 | 127 | Teva Pharmaceuticals USA, Inc. ($10,215) |
| 2023 | $21,847 | 143 | ABBVIE INC. ($9,627) |
| 2022 | $10,907 | 94 | Teva Pharmaceuticals USA, Inc. ($5,016) |
| 2021 | $19,593 | 216 | AbbVie Inc. ($10,189) |
| 2020 | $24,512 | 196 | Teva Pharmaceuticals USA, Inc. ($12,884) |
| 2019 | $40,330 | 179 | Alkermes, Inc. ($18,789) |
| 2018 | $14,692 | 111 | Teva Pharmaceuticals USA, Inc. ($9,834) |
| 2017 | $8,086 | 90 | Teva Pharmaceuticals USA, Inc. ($4,251) |
All Payment Transactions
1,156 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.92 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: CNS | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: Central Nervous System | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Central Nervous System | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Neurology | ||||||
| 10/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Neuropsychiatry | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 507 | 1,753 | $225,962 | $91,138 |
| 2022 | 8 | 667 | 2,226 | $281,917 | $113,983 |
| 2021 | 13 | 932 | 3,074 | $598,356 | $198,222 |
| 2020 | 11 | 902 | 2,597 | $356,516 | $111,374 |
Total Patients
3,008
Total Services
9,650
Medicare Billing
$514,717
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 230 | 1,204 | $142,425 | $53,599 | 37.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 111 | $22,200 | $13,676 | 61.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 174 | $26,100 | $12,544 | 48.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 34 | 41 | $9,777 | $3,609 | 36.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 69 | $9,960 | $3,511 | 35.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 11 | 11 | $2,750 | $1,661 | 60.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 52 | 81 | $8,100 | $1,182 | 14.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 45 | $3,375 | $711.55 | 21.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 17 | $1,275 | $644.30 | 50.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 267 | 1,234 | $143,850 | $59,210 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 228 | $34,180 | $16,015 | 46.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 117 | $23,400 | $15,145 | 64.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 181 | 533 | $53,300 | $12,408 | 23.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 30 | 31 | $10,075 | $4,256 | 42.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 23 | 25 | $5,375 | $2,364 | 44.0% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 16 | 17 | $4,437 | $2,336 | 52.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 41 | $7,300 | $2,248 | 30.8% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 14 | 376 | $206,800 | $64,299 | 31.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 197 | 703 | $83,025 | $36,728 | 44.2% |
| 90870 | Shock treatment and monitoring | Facility | 2021 | 31 | 288 | $86,400 | $23,620 | 27.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 237 | 709 | $70,900 | $16,938 | 23.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 124 | $24,800 | $16,839 | 67.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 145 | $21,750 | $10,517 | 48.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 49 | 55 | $17,875 | $7,398 | 41.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 124 | $24,160 | $6,850 | 28.4% |
About Dr. Nasri Ghaly, MD
Dr. Nasri Ghaly, MD is a Acupuncturist healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063479939.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nasri Ghaly, MD has received a total of $154,794 in payments from pharmaceutical and medical device companies, with $14,827 received in 2024. These payments were reported across 1,156 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($117,971).
As a Medicare-enrolled provider, Ghaly has provided services to 3,008 Medicare beneficiaries, totaling 9,650 services with total Medicare billing of $514,717. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Acupuncturist
- Other Specialties Psychiatry
- Location Syracuse, NY
- Active Since 04/26/2006
- Last Updated 08/08/2013
- Taxonomy Code 171100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063479939
Products in Payments
- AUSTEDO (Drug) $56,400
- VRAYLAR (Drug) $30,535
- ARISTADA (Drug) $19,775
- Austedo XR (Drug) $12,585
- UBRELVY (Drug) $11,770
- Aristada 441 mg (Drug) $3,756
- CAPLYTA (Drug) $3,408
- Auvelity (Drug) $2,631
- ApneaLink (Device) $2,400
- LATUDA (Drug) $1,789
- REXULTI (Drug) $1,300
- HETLIOZ (Drug) $964.24
- TRINTELLIX (Drug) $651.51
- SD809-TD (Drug) $594.33
- INGREZZA (Drug) $515.71
- SPRAVATO (Drug) $493.53
- Fanapt (Drug) $422.37
- PERSERIS (Drug) $421.34
- INVEGA SUSTENNA (Drug) $373.42
- XYWAV (Drug) $293.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acupuncturist Doctors in Syracuse
Chi Heon Yi, L. Ac, L. AC
Acupuncturist
Acupuncturist
Stephanie Chow, L.ac., M.s, L.AC., M.S
Acupuncturist
Acupuncturist
Debra Gertz, L.ac, L.AC
Acupuncturist
Acupuncturist
Joshua Swart, L.ac, L.AC
Acupuncturist
Acupuncturist
Paola Waite, L. Ac, L. AC
Acupuncturist
Acupuncturist
Mr. Gerard Rios
Acupuncturist
Acupuncturist